Katherine Stueland - 09 Sep 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Signature
/s/ Bridget Brown, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
09 Sep 2025
Net transactions value
-$468,297
Form type
4
Filing time
11 Sep 2025, 16:07:22 UTC
Previous filing
31 Jul 2025
Next filing
18 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stueland Katherine Chief Executive Officer, Director C/O GENEDX HOLDINGS CORP., 333 LUDLOW ST., NORTH TOWER, 6TH FLOOR, STAMFORD /s/ Bridget Brown, Attorney-in-Fact 11 Sep 2025 0001689575

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $0 +6,546 +190% $0.000000 9,986 09 Sep 2025 Direct F1
transaction WGS Class A Common Stock Sale $465,974 -3,639 -36% $128.05 6,347 09 Sep 2025 Direct F2
transaction WGS Class A Common Stock Sale $2,323 -18 -0.28% $129.08 6,329 09 Sep 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Options Exercise $0 -6,546 -17% $0.000000 32,733 09 Sep 2025 Class A Common Stock 6,546 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3 Following the reported sales, in addition to the 6,329 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 463,289 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.
F4 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.